Response to 'NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors' by Xiang-Yu Meng - David A Schoenfeld; Jasmine I Caulfield; Lilach Aizenbud; Ana Luisa Perdigoto; Matthew R Austin; Jacqueline E Mann (Journal for ImmunoTherapy of Cancer)